Use

This test detects phosphorylated tau181 (p‑tau181) proteins, which are hallmark biomarkers involved in the diagnosis and staging of Alzheimer’s disease. Plasma concentrations of p‑tau181 increase over time as Alzheimer’s disease progresses, enabling less invasive, practical, and cost‑effective monitoring over time and helping guide care pathways and risk assessment for cognitive decline.